BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17238983)

  • 41. The problem of post-breast cancer lymphedema: impact and measurement issues.
    Armer JM
    Cancer Invest; 2005; 23(1):76-83. PubMed ID: 15779870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Lymphedema of the arm after radical breast cancer surgery; staging-justified therapy and the possibilities of prophylaxis].
    Henningsen B; Amberger H; Reinheimer E
    Z Lymphol; 1979 Jun; 3(1):9-13. PubMed ID: 539066
    [No Abstract]   [Full Text] [Related]  

  • 43. Reliability and validity of arm volume measurements for assessment of lymphedema.
    Taylor R; Jayasinghe UW; Koelmeyer L; Ung O; Boyages J
    Phys Ther; 2006 Feb; 86(2):205-14. PubMed ID: 16445334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial.
    Dayes IS; Levine MN; Julian JA; Pritchard KI; D'Souza DP; Kligman L; Reise D; Wiernikowski JA; Bonilla L; Whelan TJ
    Breast Cancer Res Treat; 2008 Jul; 110(2):337-42. PubMed ID: 17851756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
    Shah C; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):907-14. PubMed ID: 21945108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Difficulties with defining lymphoedema after axillary dissection for breast cancer.
    Asim M; Cham A; Banerjee S; Nancekivell R; Dutu G; McBride C; Cavanagh S; Lawrenson R; Campbell I
    N Z Med J; 2012 Mar; 125(1351):29-39. PubMed ID: 22426609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erysipelas of the upper extremity following locoregional therapy for breast cancer.
    El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO
    Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center.
    Abu-Rustum NR; Alektiar K; Iasonos A; Lev G; Sonoda Y; Aghajanian C; Chi DS; Barakat RR
    Gynecol Oncol; 2006 Nov; 103(2):714-8. PubMed ID: 16740298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of life and lymphedema following breast cancer.
    Heiney SP; McWayne J; Cunningham JE; Hazlett LJ; Parrish RS; Bryant LH; Vitoc C; Jansen K
    Lymphology; 2007 Dec; 40(4):177-84. PubMed ID: 18365532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study.
    Clark B; Sitzia J; Harlow W
    QJM; 2005 May; 98(5):343-8. PubMed ID: 15820971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of dose and volume on lymphedema.
    Nardone L; Palazzoni G; D'Angelo E; Deodato F; Gambacorta MA; Miccichè F; Morganti AG
    Rays; 2005; 30(2):149-55. PubMed ID: 16294908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.
    Hayes SC; Rye S; Battistutta D; Newman B
    Lymphology; 2010 Dec; 43(4):178-87. PubMed ID: 21446573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy.
    Atahan IL; Ozyigit G; Yildiz F; Gurkaynak M; Selek U; Sari S; Hayran M
    Breast J; 2008; 14(3):245-9. PubMed ID: 18433402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphedema secondary to postmastectomy radiation: incidence and risk factors.
    Hinrichs CS; Watroba NL; Rezaishiraz H; Giese W; Hurd T; Fassl KA; Edge SB
    Ann Surg Oncol; 2004 Jun; 11(6):573-80. PubMed ID: 15172932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer lymphedema: pathophysiology and risk reduction guidelines.
    Ridner SH
    Oncol Nurs Forum; 2002 Oct; 29(9):1285-93. PubMed ID: 12370698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema.
    Johansson K; Albertsson M; Ingvar C; Ekdahl C
    Lymphology; 1999 Sep; 32(3):103-10. PubMed ID: 10494522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upper limb function and quality of life in breast cancer related lymphedema: a cross-sectional study.
    Pinto M; Gimigliano F; Tatangelo F; Megna M; Izzo F; Gimigliano R; Iolascon G
    Eur J Phys Rehabil Med; 2013 Oct; 49(5):665-73. PubMed ID: 23698473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer.
    Bar Ad V; Cheville A; Solin LJ; Dutta P; Both S; Harris EE
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):85-90. PubMed ID: 19427748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reducing postoperative seroma by closing of axillary space.
    Benjasirichai V; Piyapant A; Pokawattana C; Dowreang J
    J Med Assoc Thai; 2007 Nov; 90(11):2321-5. PubMed ID: 18181314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.